The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment

Brain14.50
Volume: 141, Issue: 7, Pages: 2047 - 2054
Published: Apr 23, 2018
Abstract
Benign brain tumours may be hormone sensitive. To induce physical characteristics of the desired gender, transgender individuals often receive cross-sex hormone treatment, sometimes in higher doses than hypogonadal individuals. To date, long-term (side) effects of cross-sex hormone treatment are largely unknown. In the present retrospective chart study we aimed to compare the incidence of common benign brain tumours: meningiomas, pituitary...
Paper Details
Title
The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment
Published Date
Apr 23, 2018
Journal
Volume
141
Issue
7
Pages
2047 - 2054
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.